Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: A randomised, double-blind, parallel-group study

International Journal of Geriatric Psychiatry

Volumn 27, Issue 3, 2012, Pages 296-304

  De Deyn, Peter Paul ^a   Eriksson, Hans ^b   Svensson, Hanna ^c  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ASTRAZENECA   (United Kingdom)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

agitation; Alzheimer's disease; older; psychosis; quetiapine

Indexed keywords

QUETIAPINE;

AGED; AGGRESSION; AGITATION; ALZHEIMER DISEASE; ARTICLE; BLEEDING; CLINICAL ASSESSMENT TOOL; CLINICAL GLOBAL IMPRESSION SCALE; COHEN MANSFIELD AGITATION INVENTORY; COMPLETE HEART BLOCK; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXTENDED RELEASE FORMULATION; FATIGUE; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; IMMEDIATE RELEASE FORMULATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORTHOSTATIC HYPOTENSION; PHASE 3 CLINICAL TRIAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; URINARY TRACT INFECTION; VOMITING; WEIGHT GAIN; XEROSTOMIA;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; DELAYED-ACTION PREPARATIONS; DIBENZOTHIAZEPINES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; PSYCHOMOTOR AGITATION; PSYCHOTIC DISORDERS;

EID: 84856325555     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2720     Document Type: Article

References (10)

1. Ballard C, Margallo-Lana M, Juszczak E, et al,. 2005. Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial. BMJ 330: 874.
2. Katila H, Mezhebovsky I, Mulroy A, et al,. 2009. Efficacy and tolerability of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder (MDD). World J Biol Psychiatry 10: 225.
3. Kelly DL, Conley RR,. 2005. Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine. J Clin Psychiatry 66: 80-84.
4. Kobak KA, Kane JM, Thase ME, et al,. 2007. Why do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms? J Clin Psychopharmacol 27: 1-5. (Pubitemid 46105756)
5. Lyketsos CG,. 2007. Neuropsychiatric symptoms (behavioural and psychological symptoms of dementia) and the development of dementia treatments. Int Psychogeriatr 19: 409-420. (Pubitemid 46707421)
6. Magi K, Mezhebovsky I, She F, et al,. 2009. Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with generalised anxiety disorder (GAD). World J Biol Psychiatry 10: 239.
7. Sink KM, Holden KF, Yaffe K,. 2005. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 293: 596-608. (Pubitemid 40171242)
8. Tariot PN, Salzman C, Yeung PP, et al,. 2000. Long-term use of quetiapine in elderly patients with psychotic disorders. Clin Ther 22: 1068-1084.
9. Tariot PN, Schneider L, Katz IR, et al,. 2006. Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial. Am J Geriatr Psychiatry 14: 767-776. (Pubitemid 44380069)
10. Zhong KX, Tariot PN, Mintzer J, et al,. 2007. Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study. Curr Alzheimer Res 4: 81-93. (Pubitemid 46293886)